Nephro Care India

NEPHROCARE

Q: How strong is Nephro Care India balance sheet?

Balance sheet of Nephro Care India is strong.But short term working capital might become an issue for this company.

Q: Is the debt of Nephro Care India increasing or decreasing?

The debt of Nephro Care India is decreasing.Latest debt of Nephro Care India is -₹2.96 Crs as of Sep-24.This is less than Mar-24 when it was -₹2.53 Crs.

Q: Is Nephro Care India stock expensive?

Nephro Care India is not expensive.Latest PE of Nephro Care India is 57.42, while 3 year average PE is 96.03. Also latest EV/EBITDA of Nephro Care India is 0 while 3yr average is 51.52.

Price

Micro Cap

₹256 Cr.

New to Zerodha? Sign-up for free.

Nephro Care India, established in 2014, is a comprehensive medical service provider for renal patients. Based in Kolkata, it offers a wide range of clinical and lifestyle solutions, focusing on renal insufficiency treatment. The company's treatment framework addresses lifestyle, physiological, and spiritual aspects of wellness.

Nephro Care India, established in 2014, is a comprehensive medical service provider for renal patie… More

Low

124

52W Range

High

379

56.76

Sector PE

39.58

P/B

Div.Yield

ROE

29.36%

EBIDTA

ROCE

42.01

EPS

New to Zerodha? Sign-up for free.

Share Price
Financials
Revenue mix
Shareholdings
Peers
Forensics

This data is currently unavailable for this company.

Summary
Profit & Loss
Balance sheet
Cashflow

View Detailed Summary

This data is currently unavailable for this company.

Yearly | Quarterly

(In Cr.)

(In Cr.)
This data is currently unavailable for this company.

Financial Ratio's

(In %)

Detailed P&L Report

(In Cr.)

Detailed Balance Sheet

Financial Year (In Cr.)

Detailed Cash Flow

Product wise
Location wise

NEPHROCARE
Revenue Mix

Latest

Historic

This data is currently unavailable for this company.

NEPHROCARE
Revenue Mix

Latest

Historic

This data is currently unavailable for this company.

More Info

Shareholdings

Holders

Detailed Shareholdings

This data is currently unavailable for this company.

Peers

Detailed Peers

Forensics

View Detailed Forensics

Recent events

News
Corporate Actions

This data is currently unavailable for this company.

More Micro Cap Ideas

See similar 'Micro' cap companies with recent activity

Promoter Buying

Companies where the promoters are bullish

Detailed List

Capex

Companies investing on expansion

Detailed List

Superstar Investor

Companies where well known investors have invested

Detailed List

Popular questions

Business
Financials
Share Price
Shareholdings

What does Nephro Care India do?

Nephro Care India was incorporatedin the year 2014 with an object of providing comprehensive medical services for renal patients. The company is a one stop treatment centre based in Kolkata that offers a wide range of clinical and lifestyle solutions and services and renal insufficiency treatment to patients. The treatment framework covers the entire range of lifestyle, physiological and spiritual aspects of wellness.

Who are the competitors of Nephro Care India?

Nephro Care India major competitors are Aashka Hospitals, Unihealth Hospitals, Maitreya Medicare, Asarfi Hospital Ltd., Fortis MalarHospital, Lotus Eye Hospital, Vaidya Sane Ayur Lab. Market Cap of Nephro Care India is ₹259 Crs. While the median market cap of its peers are ₹180 Crs.

Is Nephro Care India financially stable compared to its competitors?

Nephro Care India seems to be financially stable compared to its competitors. The probability of it going bankrupt or facing a financial crunch seem to be lower than its immediate competitors.

Does Nephro Care India pay decent dividends?

The company seems to be paying a very low dividend. Investors need to see where the company is allocating its profits. Nephro Care India latest dividend payout ratio is 0% and 3yr average dividend payout ratio is 0%

How has Nephro Care India allocated its funds?

Companies resources are majorly tied in miscellaneous assets

How strong is Nephro Care India balance sheet?

Balance sheet of Nephro Care India is strong. But short term working capital might become an issue for this company.

Is the profitablity of Nephro Care India improving?

The profit is oscillating. The profit of Nephro Care India is ₹2.95 Crs for TTM, ₹4.41 Crs for Mar 2024 and ₹2.37 Crs for Mar 2023.

Is the debt of Nephro Care India increasing or decreasing?

The debt of Nephro Care India is decreasing. Latest debt of Nephro Care India is -₹2.96 Crs as of Sep-24. This is less than Mar-24 when it was -₹2.53 Crs.

Is Nephro Care India stock expensive?

Nephro Care India is not expensive. Latest PE of Nephro Care India is 57.42, while 3 year average PE is 96.03. Also latest EV/EBITDA of Nephro Care India is 0 while 3yr average is 51.52.

Has the share price of Nephro Care India grown faster than its competition?

There is not enough historical data for the companies share price.

Is the promoter bullish about Nephro Care India?

Promoters seem to be bullish about the company. Latest quarter promoter holding is 61.44% and last quarter promoter holding is 61.38%.

Are mutual funds buying/selling Nephro Care India?

There is Insufficient data to gauge this.

NEPHROCARE

Share Price

Financials

Revenue mix

Shareholdings

Peers

Forensics

Summary

Profit & Loss

Balance sheet

Cashflow

Product wise

Location wise

Recent events

News

Corporate Actions

More Micro Cap Ideas

Promoter Buying

Capex

Superstar Investor

Popular questions

Business

Financials

Share Price

Shareholdings

What does Nephro Care India do?

Who are the competitors of Nephro Care India?

Is Nephro Care India financially stable compared to its competitors?

Does Nephro Care India pay decent dividends?

How has Nephro Care India allocated its funds?

How strong is Nephro Care India balance sheet?

Is the profitablity of Nephro Care India improving?

Is the debt of Nephro Care India increasing or decreasing?

Is Nephro Care India stock expensive?

Has the share price of Nephro Care India grown faster than its competition?

Is the promoter bullish about Nephro Care India?

Are mutual funds buying/selling Nephro Care India?